Study safety and effectiveness of a reduce to quit approach using varenicline versus placebo

Mise à jour : Il y a 4 ans
Référence : EUCTR2010-021788-33

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective is to compare the efficacy of varenicline to placebo for smoking cessation during the last 10 weeks of treatment in subjects who are not willing/able to make an abrupt quit attempt but are willing to reduce their smoking with the ultimate goal of quitting.


Critère d'inclusion

  • SMOKING CESSATION